Antiperistaltic agents to avoid in C. diff

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 53
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2019-04-19T01:00:02-04:00",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "ECRI Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: List of Antiperistaltic agents to avoid in C. diff),(Data Element Scope: This valueset is intended to work with the data element type, Medication),(Inclusion Criteria: Search terms included: loper* Diphenoxylate),(Exclusion Criteria: None)",
  "name" : "AntiperistalticAgentsToAvoidInCDiff",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1190568",
      "display" : "atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1190572",
      "display" : "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1190641",
      "display" : "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet [Lomotil]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1190646",
      "display" : "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet [Lonox]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1250685",
      "display" : "loperamide hydrochloride 0.133 MG/ML Oral Suspension",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1250693",
      "display" : "loperamide hydrochloride 0.133 MG/ML Oral Suspension [Imodium]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1426827",
      "display" : "loperamide hydrochloride 2 MG / simethicone 125 MG Oral Tablet [Imodium Multi-Symptom Relief]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1432291",
      "display" : "loperamide hydrochloride 2 MG/ML Oral Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "977986",
      "display" : "loperamide hydrochloride 0.2 MG/ML Oral Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "977998",
      "display" : "loperamide hydrochloride 2 MG / simethicone 125 MG Chewable Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978000",
      "display" : "loperamide hydrochloride 2 MG / simethicone 125 MG Chewable Tablet [Imodium Advanced]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978001",
      "display" : "loperamide hydrochloride 2 MG / simethicone 125 MG Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978006",
      "display" : "loperamide hydrochloride 2 MG Oral Capsule",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978009",
      "display" : "loperamide hydrochloride 2 MG Oral Capsule [Imodium]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978010",
      "display" : "loperamide hydrochloride 2 MG Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978012",
      "display" : "loperamide hydrochloride 2 MG Oral Tablet [Diamode]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978013",
      "display" : "loperamide hydrochloride 2 MG Oral Tablet [Imodium]",
      "version" : "11042024"
    } ],
    "total" : 17,
    "identifier" : "urn:uuid:8fa07e7c-28eb-4ac5-b8ee-522da6595c94",
    "timestamp" : "2024-12-10T04:05:04-05:00"
  },
  "title" : "Antiperistaltic agents to avoid in C. diff",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "ECRI Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-05-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2019-04-19",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "038b0522-1293-474a-ae74-f7a98e4f001e",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658"
  } ],
  "version" : "20190419"
}